Bright Minds Biosciences (DRUG) Net Income (2020 - 2026)
Bright Minds Biosciences (DRUG) posted Net Income of -$7.6 million for Q1 2026, down 40.59% on a QoQ basis from -$5.4 million in Q4 2025, and down 483.85% year-over-year from $2.0 million in Q1 2025.
Bright Minds Biosciences (DRUG) Net Income (2020 - 2026) Analysis & Trends
Bright Minds Biosciences' Net Income history runs 7 years deep, the most recent figure standing at -$7.6 million for Q1 2026.
Powered by 
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | Net Income (Qtr) |
|---|---|---|---|---|---|
| 1 | Oculis Holding AG | 68,785.72 Bn | 68,785.72 Bn | - | -37.09 Mn |
| 2 | Nanobiotix | 1,895.57 Bn | 1,895.51 Bn | - | - |
| 3 | BeOne Medicines | 471.35 Bn | 466.56 Bn | 1.35 Bn | 227.36 Mn |
| 4 | NuCana | 279.75 Bn | 279.75 Bn | - | -3.31 Mn |
| 5 | Vertex Pharmaceuticals | 120.24 Bn | 113.00 Bn | 2.59 Bn | 1.03 Bn |
| 6 | Regeneron Pharmaceuticals | 67.80 Bn | 59.04 Bn | 3.31 Bn | 727.20 Mn |
| 7 | Belite Bio | 62.51 Bn | 62.51 Bn | - | -26.94 Mn |
| 8 | Argenx Se | 57.38 Bn | 57.38 Bn | 1.41 Bn | 362.00 Mn |
| 9 | Revolution Medicines | 37.78 Bn | 37.78 Bn | - | -453.82 Mn |
| 10 | Bright Minds Biosciences | 498.53 Mn | 498.53 Mn | - | -7.63 Mn |
Historic Data
Download Data| Date | Value |
|---|---|
| Mar 31, 2026 | -7.63 Mn |
| Dec 31, 2025 | -5.42 Mn |
| Jun 30, 2025 | -7.97 Mn |
| Mar 31, 2025 | 1.99 Mn |
| Dec 31, 2024 | 35,513.28 |
| Jun 30, 2024 | -168,091.41 |
| Mar 31, 2024 | 2.93 Mn |
| Dec 31, 2023 | -1.24 Mn |
| Jun 30, 2023 | 1.09 Mn |
| Mar 31, 2023 | 1.52 Mn |
| Dec 31, 2022 | 1.72 Mn |
| Jun 30, 2022 | 2.09 Mn |
| Mar 31, 2022 | 3.54 Mn |
| Dec 31, 2021 | 3.85 Mn |
| Jun 30, 2021 | 2.87 Mn |
| Mar 31, 2021 | 1.25 Mn |
| Dec 31, 2020 | 511,669.18 |